(Q46506219)

22 December 2017

title

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease (English)

1 reference

22 December 2017

0 references

6

Nicola Vanacore

1 reference

22 December 2017

Roberto Raschetti

1

1 reference

22 December 2017

Marina Maggini

2

1 reference

22 December 2017

Giacoma Carla Sorrentino

3

1 reference

22 December 2017

Nello Martini

4

1 reference

22 December 2017

Bruno Caffari

5

1 reference

22 December 2017

publication date

24 May 2005

1 reference

22 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

22 December 2017

volume

61

1 reference

22 December 2017

issue

5-6

1 reference

22 December 2017

page(s)

361-368

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-005-0946-1

exact match

0 references

cites work

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0946-1

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

12 December 2020

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

12 December 2020

Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis

1 reference

12 December 2020

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

1 reference

12 December 2020

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

12 December 2020

Treatment of Alzheimer's disease: current status and new perspectives.

1 reference

12 December 2020

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00228-005-0946-1

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017